August 12, 2024
Baltimore’s Neurotech Innovation Achieves Patent Approval and Featured Cover Story in Prominent Industry Journal
(Baltimore, MD) - Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative solutions for complex brain surgeries, proudly…
August 6, 2024
Maximizing Investment Opportunities at the BioHealth Capital Region Investment Conference
The 7th Annual Investment Conference, scheduled for September 19th during the BioHealth Capital Region Week at US Pharmacopeia in Rockville,…
August 6, 2024
Emergent BioSolutions Expands NARCAN® Nasal Spray Distribution Capabilities to Enhance Customer Delivery Experience Across the Country
GAITHERSBURG, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced the introduction of a new NARCANDirect™ distribution center in Nevada to further demonstrate…
August 5, 2024
Exploring ARPA-H Innovations: Insights with Craig Gravitz and Jenica Patterson, Ph.D. on BioTalk
In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., welcomes guests from ARPA-H: Craig Gravitz,…
August 1, 2024
PMLIVE: GSK and Flagship Pioneering partner in deal worth up to $7bn to discover medicines and vaccines
GSK and Flagship Pioneering have entered into a partnership worth up to $7bn to discover and develop novel medicines and…
August 1, 2024
Theriva™ Biologics Receives Rare Pediatric Drug Designation by the U.S. FDA for VCN-01 for the Treatment of Retinoblastoma
ROCKVILLE, Md., July 31, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics…
